Key points for investors:
- Strong order momentum: Q1 order intake was a record EUR 149.3m (book-to-bill 1.73). Order strength was broad across customers, applications and regions (notably Europe and North America improved; China is returning). The order book stood at EUR 330.1m at quarter end, with ~EUR 300m in tool orders.
- Revenue and seasonality: Q1 revenue of EUR 86.5m was the expected low point (reflects lower order intake from summer 2025 and ~6 month lead times). Management expects sequential sales improvement through 2026.
- Backlog visibility and conversion: Management expects ~EUR 255m of current tool orders to convert to sales in 2026; ~EUR 45m is scheduled beyond 2026 (supporting early 2027 backlog).
- Profitability & guidance: Gross margin around 36% (guidance corridor 35–37%); Q1 EBIT depressed by fixed-cost underabsorption. Company confirms full-year guidance: sales EUR 425–485m and EBIT margin 8–10% (gross margin broadly stable). Management expects EBIT margin to improve as coverage rises.
- Segment highlights & product mix risk: Advanced Backend Solutions saw strong bonder order intake but Q1 sales were weak (bonding down 65% YoY), producing an unfavorable mix and pressure on profitability. Photomask Solutions saw ~EUR 50m order intake (improvement; ~1/3 from China) but Q1 sales were lower. New / next‑gen product launches (mid‑end cleaner, MaskTrack Smart, next‑gen UV panel scanner, GreenTech) may contribute more in 2027+, though timing and ramp risks remain.
- Capacity and execution: Management is ramping flexible manufacturing capacity (Taiwan and Germany) and hiring flex labor to meet demand; they report ability to accept more orders for 2026 and expect to fulfill them.
- Cash & balance sheet: Cash increased to EUR 120.9m; free cash flow improved to EUR 23.2m in Q1. Inventory rose (WIP) as tools are being built; equity ratio ~60.7%.
- Risks & unknowns: Order composition includes more long‑dated orders into 2027, so current order intake does not fully guarantee 2026 revenue. Geopolitical and input-price pressures exist (some supplier price inflation), and product launch execution/timing remain key uncertainties.
Overall: Investors should view Q1 as evidence of resurgent demand and improved order visibility, but near‑term revenue will be lumpy due to product mix and timing; management is reaffirming its full‑year guidance while highlighting backlog conversion and execution as the drivers to watch.
Sign In
Buy SESMF
